product summary
company name : 
Atlas Antibodies
product type : 
antibody
product name : 
Anti-CD8A
catalog : 
AMAb90883
quantity : 
100 µl
clonality : 
monoclonal
host : 
mouse
conjugate : 
nonconjugated
clone name : 
reactivity : 
human
application : 
immunohistochemistry
more info or order : 
image
image 1 : 

Immunohistochemical staining of human tonsil shows strong immunoreactivity in a subset of lymphoid cells outside the reaction centra.
image 2 : 

Immunohistochemical staining of human rectum shows strong positivity in a subset of lymphoid cells in lamina propria.
image 3 : 

Immunohistochemical staining of human small intestine shows strong immunoreactivity in a subset of lymphoid cells in lamina propria.
product information
product number : 
AMAb90883
product name : 
Anti-CD8A
clone number : 
CL1529
ensembl gene id : 
ENSG00000153563
gene description : 
CD8a molecule
alternative names : 
CD8
supportive applications : 
IHC
clonality : 
Monoclonal
category : 
Primary
antigen type : 
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
antigen sequence : 
AASPTFLLYLSQNKPKAAEGLDTQRFSGKRLGDTFVLTL
SDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTP
APRPPT
SDFRRENEGYYFCSALSNSIMYFSHFVPVFLPAKPTTTP
APRPPT
epitope specificity : 
Binds to an epitope located within the peptide sequence AASPTFLLYLSQNKP as determined by overlapping synthetic peptides.
host animal : 
Mouse
species reactivity : 
Human
isotype : 
IgG1
purification method : 
Protein A purified
buffer : 
40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
storage : 
Store at +4°C for short term storage. Long time storage is recommended at -20°C.
unit : 
100 µl
uniprot id : 
P01732
conjugate : 
unconjugated
antigen sequence identity mouse : 
46
antigen sequence identity rat : 
44
more info or order : 
company information
Atlas Antibodies
AlbaNova University Center
SE-106 91 Stockholm
SE-106 91 Stockholm
contact@atlasantibodies.com
www.atlasantibodies.com46 8 54 59 58 50
headquarters: Sweden
review
product type
browse more products
questions and comments
